Repurposing anticancer drugs for COVID-19-induced inflammation, immune dysfunction, and coagulopathy.

Auteurs : Saini KS, Lanza C, Romano M, de Azambuja E, Cortes J, de Las Heras B, de Castro J, Lamba Saini M, Loibl S, Curigliano G, Twelves C, Leone M, Patnaik MM
Année : 2020
Journal : Br J Cancer
Volume : 123
Pages : 694-697